On August 31, 2009
Immunomedics: P-Values? Phooey! These Lupus Data Look Great, Trust Us!
Last week’s press release from Immunomedics and partner UCB concerning lupus drug epratuzumab’s success in a Phase IIb trial seemed to be missing something — statistical significance.
0 Comments